ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

REDX Redx Pharma Plc

13.50
2.50 (22.73%)
17 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Redx Pharma Plc LSE:REDX London Ordinary Share GB00BSNB6S51 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.50 22.73% 13.50 13.00 14.00 13.75 11.00 11.25 1,069,536 16:25:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.2M -33.16M -0.0852 -1.58 52.51M

Redx Pharma plc Holding(s) in Company (4280K)

21/09/2016 8:51am

UK Regulatory


TIDMREDX TIDMAV.

RNS Number : 4280K

Redx Pharma plc

21 September 2016

 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
------------------------------------------------------------------------ 
 
 1. Identity of the issuer or the underlying issuer 
  of existing shares to which voting rights are 
  attached: (ii) 
--------------------------------------------------------------------------------------------------------------- 
 2 Reason for the notification 
  (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------  ------------------------------------------ 
 An acquisition or disposal                                           Redx Pharma Plc 
  of voting rights 
-------------------------------------------------------------------  ------------------------------------------ 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already 
  issued to which voting rights are attached 
--------------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
----------------------------------------------------------------------  --------------------------------------- 
 An event changing the breakdown of voting rights 
----------------------------------------------------------------------  --------------------------------------- 
 Other (please specify): 
----------------------------------------------------------------------  --------------------------------------- 
 3. Full name of person(s) subject to the 
  notification obligation: (iii) 
----------------------------------------------------------------------  --------------------------------------- 
 4. Full name 
  of shareholder(s) 
  (if different 
  from 3.):(iv) 
---------------------------------------------------------------  -----  --------------------------------------- 
 5. Date of the transaction                                         Aviva plc & its subsidiaries 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------------  -------------------------------------------- 
 6. Date on which issuer                                                 Registered Holder: 
  notified: 
                                                                         BNY Norwich Union Nominees 
                                                                         Limited 321,098* 
                                                                         Chase (GA Group) Nominees 
                                                                         Limited 4,685,774* 
                                                                         State Street Nominees Limited 
                                                                         1,216,783* 
 
                                                                         *denotes direct interest 
 
                                                                         Chase (GA Group) Nominees 
                                                                         Limited 319,659 
 
                                                                         Chase Nominees Limited 178,590 
-----------------------------------------------------------------  -------------------------------------------- 
 7. Threshold(s) that is/are                                        19 September 2016 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------------  -------------------------------------------- 
 
 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type           Situation previous              Resulting situation after the 
  of                   to the triggering               triggering transaction 
  shares               transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------------  ------------------------------  --------------------------------------------------------- 
                      Number              Number      Number        Number of               % of voting 
                       of                  of          of shares     voting                  rights (x) 
                       Shares              Voting                    rights 
                                           Rights 
-------------------  ------------------  ----------  ------------  ----------------------  ------------------- 
                                                      Direct        Direct      Indirect    Direct   Indirect 
                                                                     (xi)        (xii) 
-------------------  ------------------  ----------  ------------  ----------  ----------  -------  ---------- 
 Ordinary 
  Shares 
 
 
  GB00BSNB6S51        7,754,352           7,754,352   6,721,904     6,223,655   498,249     6.65%    0.54% 
                     ------------------  ----------  ------------  ----------  ----------  -------  ---------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of financial    Expiration          Exercise/                 Number of voting        % of voting 
  instrument           date                Conversion                rights that             rights 
                       (xiii)              Period (xiv)              may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-------------------  ------------------  ------------------------  ----------------------  ------------------- 
 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
------------------------------------------------------ 
 Number of voting rights   Percentage of voting rights 
------------------------  ---------------------------- 
 6,721,904                 7.19% 
------------------------  ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
--------------------------------------------------------------- 
 The voting rights are managed and controlled by Aviva 
  Investors Global Services Limited, with the following 
  chain of controlled undertakings:- 
 
  Aviva Investors Global Services Limited: 
   *    Aviva plc (Parent Company) 
 
 
   *    Aviva Group Holdings Limited (wholly owned subsidiary 
        of Aviva plc) 
 
 
   *    Aviva Investors Holdings Limited (wholly owned 
        subsidiary of Aviva Group Holdings Limited) 
 
 
   *    Aviva Investors Global Services Limited (wholly owned 
        subsidiary of Aviva Investors Holdings Limited) 
 
 Proxy Voting: 
--------------------------------------------------------------- 
 10. Name of the proxy holder:                 See Section 4 
--------------------------------------------  ----------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
--------------------------------------------  ----------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
--------------------------------------------  ----------------- 
 
 
 
  13. Additional information:       Figures are based on a total 
                                    number of voting rights of 
                                    93,552,638 as per the Company's 
                                    'Result of General Meeting 
                                    and Issue of Equity' Announcement 
                                    of 13 April 2016. 
-------------------------------  ------------------------------------ 
 14. Contact name:                    Neil Whittaker, Aviva plc 
-------------------------------  ------------------------------------ 
 15. Contact telephone number:        01603 684420 
-------------------------------  ------------------------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLGRGDCRSDBGLB

(END) Dow Jones Newswires

September 21, 2016 03:51 ET (07:51 GMT)

1 Year Redx Pharma Chart

1 Year Redx Pharma Chart

1 Month Redx Pharma Chart

1 Month Redx Pharma Chart

Your Recent History

Delayed Upgrade Clock